June 18th, 2012
This week’s topics include imaging risks, oral contraceptives and the risk for MI and stroke, smoking and mortality in those aged 60 and older, and wasteful spending on cardiovascular tests.
October 26th, 2011
A large new study from Denmark provides the best evidence yet that third-generation oral contraceptives (OCs) containing drospirenone, desogestrel, or gestodene (sometimes used to treat dysmenorrhea) are associated with twice the risk for venous thromboembolism (VTE) as second-generation OCs containing levonorgestrel. In a paper published in BMJ, Øjvind Lidegaard and colleagues analyzed data from national registries containing more […]